PTK2B and ulcerative colitis: Next, we tested the impact of PYK2 inhibition in biopsies derived from the colonic mucosa of patients with active ulcerative colitis by measuring cytokine production at concentrations not affecting cell viability in these samples (Supplementary Fig. 8b, c).